|
Market Closed -
Bombay S.E.
14:02:28 08/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 5,185.35 INR | +0.10% |
|
-3.14% | -5.81% |
| 08-14 | Alkem Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026 | |
| 08-14 | Alkem Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Sales 2026 by Business Segment
Sales 2026 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 106B | 116B | 127B | 130B | 147B | |||||
Total Assets | 141B | 138B | 156B | 177B | 209B | |||||
Interest Expense | -309M | -809M | -804M | -1.05B | -1.41B | |||||
Income Tax Expense | 1.64B | 2.98B | 2.12B | 3.11B | 5.18B | |||||
CAPEX | -3.39B | -2.33B | -2.59B | -6.76B | -6.17B | |||||
EBT | 18.44B | 13.05B | 20.23B | 25.27B | 28.71B | |||||
D&A | 2.94B | 2.99B | 2.86B | 3.44B | 3.68B | |||||
Net Income | 16.46B | 9.84B | 17.96B | 21.65B | 23.02B |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
India | 75.27B | 81.6B | 86.62B | 91.44B | 99.75B | |||||
Total Assets | 25.9B | 25.58B | 25.85B | 23.87B | 27.42B | |||||
| - | - | - | - | 29.62B | ||||||
United States (US) | 23.29B | 25.13B | 27.71B | 24.82B | 29.62B | |||||
Total Assets | 5.99B | 3.97B | 3.98B | 9.61B | 13.54B | |||||
| - | - | - | - | 17.75B | ||||||
Other International | 7.78B | 9.26B | 12.35B | 13.39B | 17.75B | |||||
Total Assets | 519M | 515M | 486M | 522M | 567M | |||||
| - | - | - | - | 99.75B |
Select your edition
All financial news and data tailored to specific country editions
